These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1798 related articles for article (PubMed ID: 37284149)
1. Alzheimer's disease is an inherent, natural part of human brain aging: an integrated perspective. Ferrer I Free Neuropathol; 2022 Jan; 3():. PubMed ID: 37284149 [TBL] [Abstract][Full Text] [Related]
3. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease. Volloch V; Olsen BR; Rits S Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090 [TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
7. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology. Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663 [TBL] [Abstract][Full Text] [Related]
8. Dysregulated protein phosphorylation: A determining condition in the continuum of brain aging and Alzheimer's disease. Ferrer I; Andrés-Benito P; Ausín K; Pamplona R; Del Rio JA; Fernández-Irigoyen J; Santamaría E Brain Pathol; 2021 Nov; 31(6):e12996. PubMed ID: 34218486 [TBL] [Abstract][Full Text] [Related]
10. Have we learnt all we need to know from genetic studies - is genetics over in Alzheimer's disease? Hampel H; Lista S Alzheimers Res Ther; 2013; 5(2):11. PubMed ID: 23510020 [TBL] [Abstract][Full Text] [Related]
11. A Tau-Driven Adverse Outcome Pathway Blueprint Toward Memory Loss in Sporadic (Late-Onset) Alzheimer's Disease with Plausible Molecular Initiating Event Plug-Ins for Environmental Neurotoxicants. Tsamou M; Pistollato F; Roggen EL J Alzheimers Dis; 2021; 81(2):459-485. PubMed ID: 33843671 [TBL] [Abstract][Full Text] [Related]
12. Salivary lactoferrin as biomarker for Alzheimer's disease: Brain-immunity interactions. Bermejo-Pareja F; Del Ser T; Valentí M; de la Fuente M; Bartolome F; Carro E Alzheimers Dement; 2020 Aug; 16(8):1196-1204. PubMed ID: 32543760 [TBL] [Abstract][Full Text] [Related]
13. Alzheimer's disease pathogenesis: role of aging. Harman D Ann N Y Acad Sci; 2006 May; 1067():454-60. PubMed ID: 16804026 [TBL] [Abstract][Full Text] [Related]
14. NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease. Jack CR; Bennett DA; Blennow K; Carrillo MC; Dunn B; Haeberlein SB; Holtzman DM; Jagust W; Jessen F; Karlawish J; Liu E; Molinuevo JL; Montine T; Phelps C; Rankin KP; Rowe CC; Scheltens P; Siemers E; Snyder HM; Sperling R; Alzheimers Dement; 2018 Apr; 14(4):535-562. PubMed ID: 29653606 [TBL] [Abstract][Full Text] [Related]